Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy

被引：0
|
作者：
Charkviani, Mariam
Vaughan, Lisa E.
Sandahl, Tyler B.
Lin, Yi
Leung, Nelson
Herrmann, Sandra M.
机构：
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma
    Yin, Zhao
    Zhang, Qing
    Ou, Ruiming
    Liu, Shuang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (25)
  • [22] Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Hamadeh, Issam S.
    Shekarkhand, Tala
    Rueda, Colin
    Firestone, Ross S.
    Wang, Alice X.
    Korde, Neha
    Hultcrantz, Malin L.
    Lesokhin, Alexander M.
    Mailankody, Sham
    Hassoun, Hani
    Shah, Urvi A.
    Maclachlan, Kylee
    Rajeeve, Sridevi
    Patel, Dhwani
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar B.
    Chung, David J.
    Landau, Heather J.
    Giralt, Sergio
    Usmani, Saad Z.
    Tan, Carlyn R.
    BLOOD ADVANCES, 2024, 8 (12) : 3038 - 3044
  • [23] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [24] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher J.
    Atrash, Shebli
    Khouri, Jack
    Voorhees, Peter M.
    Dima, Danai
    Simmons, Gary
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Arai, Sally
    Miklos, David B.
    Wagner, Charlotte B.
    Davis, James
    Sborov, Douglas W.
    Nishihori, Taiga
    Alsina, Melissa
    Locke, Frederick L.
    Gonzalez, Rebecca
    Kocoglu, M. Hakan
    Sannareddy, Aishwarya
    Afrough, Aimaz
    McGuirk, Joseph P.
    Shune, Leyla O.
    Patel, Krina
    Hansen, Doris K.
    BLOOD, 2022, 140 : 10377 - 10379
  • [25] ACUTE KIDNEY INJURY AND ELECTROLYTE DERANGEMENTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
    Morales, Erin
    Angelo, Joseph
    Ahmed, Nabil
    Doherty, Erin
    Yassine, Khaled
    Sinno, Mohamad
    Steffin, David
    Hsieh, Emily
    John, Tami
    Sasa, Ghadir
    Friend, Brian
    Salem, Baheyeldin
    Craddock, John
    Hegde, Meenakshi
    Omer, Bilal
    Heczey, Andras
    Martinez, Cardidad
    Heslop, Helen
    Rouce, Rayne
    Krance, Robert
    Bhar, Saleh
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S104 - S104
  • [26] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [27] Healthcare resource utilization and costs among patients with relapsed/refractory multiple myeloma treated with chimeric antigen receptor-T (CAR-T) cell therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S187 - S188
  • [28] Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S511 - S512
  • [29] Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Zu, Cheng
    Xu, Yufeng
    Wang, Yiyun
    Zhang, Mingming
    Zhao, Houli
    Fang, Xiaoyun
    Huang, He
    Hu, Yongxian
    CURRENT ONCOLOGY, 2022, 29 (02) : 490 - 496
  • [30] Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies
    Leon-Roman, Juan
    Iacoboni, Gloria
    Bermejo, Sheila
    Carpio, Cecilia
    Bolufer, Monica
    Garcia-Carro, Clara
    Sanchez-Salinas, Mario
    Alonso-Martinez, Carla
    Bestard, Oriol
    Barba, Pere
    Soler, Maria Jose
    CLINICAL KIDNEY JOURNAL, 2024, 17 (03)
12345